Trial intelligence / Profile preview

Lansoprazole/Antacid Combination for Meal-Induced Heartburn

NCT01037452Phase 2Completed

Sponsor
Novartis
Start
Dec 2009
Primary completion
Jan 2010
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of lansoprazole, calcium carbonate, Magnesium hydroxide in gastroesophageal reflux disease (GERD), sponsored by Novartis. Started Dec 2009; status: completed.

02

Drugs

lansoprazolecalcium carbonateMagnesium hydroxide
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT01037452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01037452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call